Recent Patents on CNS Drug Discovery (Discontinued)
Title:ACKNOWLEDGEMENT
Volume: 7 Issue: 3
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENT, Recent Patents on CNS Drug Discovery (Discontinued) 2012; 7 (3) . https://dx.doi.org/10.2174/157488912803252041
DOI https://dx.doi.org/10.2174/157488912803252041 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
11
Related Articles
-
Neurogenesis in the Adult Brain: Implications for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Discovery of Nesfatin-1 and Overview of Biological Actions and New Developments
Current Pharmaceutical Design Rational Design of Novel Potential p38α MAPK Inhibitors with Drug-like Properties Using Pharmacophore and Similarity-based Virtual Screening Procedures
Current Bioactive Compounds Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Applications of Indan-1,3-Dione in Heterocyclic Synthesis
Current Organic Synthesis The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities
Current Topics in Medicinal Chemistry Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Topics in Medicinal Chemistry Cellular Oxidative/Antioxidant Balance in γ-Irradiated Brain: An Update
Mini-Reviews in Medicinal Chemistry The Orphanin FQ / Nociceptin Receptor as a Novel Drug Target in Psychiatric Disorders
CNS & Neurological Disorders - Drug Targets MicroRNAs in Organogenesis and Disease
Current Molecular Medicine Galanin/GALP Receptors and CNS Homeostatic Processes
CNS & Neurological Disorders - Drug Targets Improvement of Abiotic Stress Tolerance of Crops Via Enhancement of their Antioxidant Capacity
Current Chemical Biology Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Current Drug Metabolism Meet Our Editorial Board Member
Current Alzheimer Research Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Current Pharmaceutical Design Melatonin in Autism Spectrum Disorders
Current Clinical Pharmacology New Developments in Understanding and Treating Adolescent Marijuana Dependence
Adolescent Psychiatry Dysfunctional Immune-Mediated Inflammation in Rheumatoid Arthritis Dictates that Development of Anti-Rheumatic Disease Drugs Target Multiple Intracellular Signaling Pathways
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Novel Technology for Hematopoietic Stem Cell Expansion Using Combination of Nanofiber and Growth Factors
Recent Patents on Nanotechnology Lactoferrin Suppresses Decreased Locomotor Activities by Improving Dopamine and Serotonin Release in the Amygdala of Ovariectomized Rats
Current Molecular Pharmacology